Growth Metrics

Aptevo Therapeutics (APVO) Asset Writedowns and Impairment (2016)

Aptevo Therapeutics (APVO) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $71.0 million as the latest value for Q3 2016.